Back
GlycoMimetics Vs. Arbutus Biopharma Industry Stock Comparison
Sell
50
GLYC
GlycoMimetics
Last Price:
0.32
Seasonality Move:
31.73%
Sell
36
ABUS
Arbutus Biopharma
Last Price:
3.46
Seasonality Move:
15.21%
Sell
50
GlycoMimetics (GLYC)
is a Sell
Is GlycoMimetics a Buy, Sell or Hold?
- The current GlycoMimetics [GLYC] share price is $0.33. The Score for GLYC is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- GLYC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
36
Arbutus Biopharma (ABUS)
is a Sell
Is Arbutus Biopharma a Buy, Sell or Hold?
- The current Arbutus Biopharma [ABUS] share price is $3.44. The Score for ABUS is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- ABUS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GLYC Stock Price Chart
What is GlycoMimetics's stock price today?
-
The GlycoMimetics share price today is $0.33
The current trend is moderately bearish and GLYC is experiencing slight selling pressure.
ABUS Stock Price Chart
What is Arbutus Biopharma's stock price today?
-
The Arbutus Biopharma share price today is $3.44
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABUS is experiencing selling pressure, which indicates risk of future bearish movement.
GLYC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 49.57 | Sell |
| Chaikin Money Flow: | -1087514 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.22 - 0.44) | Sell |
| Bollinger Bands (100): | (0.14 - 0.32) | Buy |
ABUS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.12 | Sell |
| Relative Strength Index (14 RSI): | 28.99 | Sell |
| Chaikin Money Flow: | -417405 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.64 - 4.06) | Sell |
| Bollinger Bands (100): | (3.55 - 4.13) | Sell |
GLYC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.4 | Sell |
| 20-day SMA: | 0.37 | Sell |
| 50-day SMA: | 0.24 | Buy |
| 200-day SMA: | 0.99 | Sell |
| 8-day EMA: | 0.38 | Sell |
| 20-day EMA: | 0.35 | Sell |
| 50-day EMA: | 0.3 | Buy |
| 200-day EMA: | 0.74 | Sell |
ABUS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.59 | Sell |
| 20-day SMA: | 3.79 | Sell |
| 50-day SMA: | 3.93 | Sell |
| 200-day SMA: | 3.37 | Buy |
| 8-day EMA: | 3.59 | Sell |
| 20-day EMA: | 3.73 | Sell |
| 50-day EMA: | 3.83 | Sell |
| 200-day EMA: | 3.43 | Buy |
GlycoMimetics Earnings Growth & GLYC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $0.01 per share.
Arbutus Biopharma Earnings Growth & ABUS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.04 per share.
GlycoMimetics Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Arbutus Biopharma Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||